Replagal agalsidase alfa regulatory update

TKTX said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Sept. 27 to discuss the company's BLA for Replagal to treat Fabry's disease. The enzyme replacement therapy alrea...